Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
DECIPHERA
Show more
Class 5: pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
Class 42: pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and clinical trials
Class 44: medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaSClass 44 – Medical & beauty services
Status timeline
- 21 Apr 2023Application filedNew Application Entered
- 12 Jan 2024Assigned to an examining attorneyAssigned To Examiner
- 13 Jan 2024Approved for publicationApproved For Pub - Principal Register
- 20 Feb 2024Published for oppositionPublished For Opposition
- 7 May 2024Registered on the Principal RegisterRegistered-Principal Register
All 11 events
| 2024-05-07 | Registered-Principal Register |
| 2024-05-07 | Notice Of Registration Confirmation Emailed |
| 2024-03-04 | Official Gazette Publication Confirmation E-Mailed |
| 2024-02-20 | Published For Opposition |
| 2024-02-02 | Notification Of Notice Of Publication E-Mailed |
| 2024-02-01 | Official Gazette Publication Confirmation E-Mailed |
| 2024-02-01 | Official Gazette Publication Confirmation E-Mailed |
| 2024-01-13 | Approved For Pub - Principal Register |
| 2024-01-12 | Assigned To Examiner |
| 2023-05-14 | New Application Office Supplied Data Entered |
| 2023-04-21 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
First use anywhere 16 May 2020 · First use in commerce 20 May 2020
Class 42 Technology & SaaS
pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and clinical trials
First use anywhere 0 Nov 2003 · First use in commerce 0 Nov 2003
Class 44 Medical & beauty services
medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma
First use anywhere 16 May 2020 · First use in commerce 20 May 2020
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 5 Jun 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.